Tag Archives: Venture Capital

The Eyes Have It According to Recent VC Funding Patterns

BIO Investor Forum

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which human body parts are experiencing the biggest rise in funding. The report was based on data from thousands of financings of startups from 1999 through the first half of 2014, provided by VentureSource, a database owned by Dow Jones & Company. And while many would assume the funding was largely pumped in to cardiovascular disease, they would be wrong. “The Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Announces Cleantech Investor Speakers for 2014 World Congress

World Congress

Emerging companies to showcase their ground-breaking achievements  A selective group of CEOs and COOs from emerging industrial biotechnology companies will present new technologies, accomplishments, and business cases during the Clean Tech Investor Sessions at the BIO World Congress on Industrial Biotechnology, the Biotechnology Industry Organization (BIO) announced today. “The Clean Tech Investor Sessions at BIO’s World Congress on Industrial Biotechnology will help facilitate these much need investment opportunities for emerging companies while granting investors a first-hand look into some of Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Driving Innovation in Breast Cancer: Startup Challenge

Driving Innovation

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for Advancing Innovation (CAI) have partnered to launch a “first of a kind” Business Plan and Start-Up Challenge for Breast Cancer (BC) inventions that have high commercial viability and are important to public health. This challenge will accelerate the commercialization of Federal agency and AF grantee BC inventions, spur economic growth, and provide Universities a platform to further develop their entrepreneurship learning portfolio. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Venture Capital Trends

Venture Capital Trends

With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s Director of Industry Research & Analysis – and the latest on venture capital trends is no exception. In the U.S., biotech VC funding is flat, and start-up money is drying up. According to the National Venture Capital Association (NCVA), U.S. VC funding for biotech fell to $4.1 billion in 2012 (figure 1). This 17% drop was greater than the 10% Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO-Europe Spring Opening Remarks

Chart

BIO’s own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring conference in Barcelona yesterday. His slides provide a snapshot of the biotech industry’s performance and highlight emerging trends in venture exits: IPOs and M&A. Takeaways from his talk include breakouts on multiple fronts for the industry: FDA approvals at highs not seen since the 1990s Orphan designation approvals at all-time highs IPOs starting to show signs of life in 2012 Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,